Peripheral blood expression profiles of bone morphogenetic proteins, tumor necrosis factor-superfamily molecules, and transcription factor Runx2 could be used as markers of the form of arthritis, disease activity, and therapeutic responsiveness.
about
Gene expression analysis in RA: towards personalized medicineIdentification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association studyIdentification of rheumatoid arthritis and osteoarthritis patients by transcriptome-based rule set generation.Blood cells transcriptomics as source of potential biomarkers of articular health improvement: effects of oral intake of a rooster combs extract rich in hyaluronic acidTargeting Fas in osteoresorptive disorders.Markers of treatment response to methotrexate in rheumatoid arthritis: where do we stand?Osteoarthritis in the Knee Joints of Göttingen Minipigs after Resection of the Anterior Cruciate Ligament? Missing Correlation of MRI, Gene and Protein Expression with Histological Scoring.Abnormal expression of key genes and proteins in the canonical Wnt/β-catenin pathway of articular cartilage in a rat model of exercise-induced osteoarthritisSerum Heme Oxygenase-1 and BMP-7 Are Potential Biomarkers for Bone Metabolism in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis.Differences in Mammalian target of rapamycin gene expression in the peripheral blood and articular cartilages of osteoarthritic patients and disease activityAdvances in osteoarthritis geneticsRheumatoid factor positivity is associated with increased joint destruction and upregulation of matrix metalloproteinase 9 and cathepsin k gene expression in the peripheral blood in rheumatoid arthritic patients treated with methotrexateAssociation of systemic and intra-articular osteoclastogenic potential, pro-inflammatory mediators and disease activity with the form of inflammatory arthritis.Emerging drugs for psoriatic arthritis.Exploring the biological basis of haemophilic joint disease: experimental studies.Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis.Temporal and spatial expression patterns of bone morphogenetic protein 3 in developing zebrafish.Increased baseline RUNX2, caspase 3 and p21 gene expressions in the peripheral blood of disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients are associated with improved clinical response to methotrexate therapy.Which clinical variables have the most significant correlation with quality of life evaluated by SF-36 survey in Croatian cohort of patient with ankylosing spondylitis and psoriatic arthritis?Association of GDF5, SMAD3 and RUNX2 polymorphisms with temporomandibular joint osteoarthritis in female Han Chinese.Bone morphogenetic protein-2 exhibits therapeutic benefits for osteonecrosis of the femoral head through induction of cartilage and bone cells.
P2860
Q26825706-07EFA8AB-A525-4CD1-A144-0743E8C03724Q28270341-0B22E6EB-AC22-430D-9B0F-CF11F41A52BCQ33766708-49F18D59-69E1-4E24-97AD-55F6DB620811Q34232764-BDCE31D8-181B-4F28-B832-883B6C83A057Q34561691-123FE63A-9D98-4997-8E9A-8E1505FC699CQ36104458-BC451F8B-B894-41A0-9D57-FE87B8C28498Q36184418-65722548-37AE-4805-80A0-AE22C0DC1E04Q36623909-88D3A4C2-4232-4C77-9626-100714C1E03AQ36985517-1DEF74FF-3CA1-49A8-8883-C8EE7ECDFEE8Q36999290-0643FA17-349B-4B55-8799-052F5BC66EE9Q37267662-7A7B85F6-7F94-4E3C-A3A8-6BF562C0575EQ37358983-6014FF24-7582-4B68-957F-4A3EE4189DD4Q37472160-622E378A-4BA0-4F1D-9DB3-17AB66DB4F0AQ37763192-2AED3099-291D-40B8-94A1-43874C4900A0Q37951686-D782EBCA-6F7D-44E1-A532-F1279A671F46Q40655784-EB95C7DD-9338-47BD-988B-CF5D07CEDF76Q42943378-15B04F13-06BE-4852-9D9F-719FF6B17A17Q48030951-AA2D5442-6AEE-4E94-805A-83D01EB4B421Q48552102-C62393CB-1060-4870-8A9D-699DBFF9A73BQ51046647-0AF057C4-5653-4F15-BC97-04F794EB9C3FQ55083268-BCDF9A02-77C7-4407-BA1F-DAEE844F784E
P2860
Peripheral blood expression profiles of bone morphogenetic proteins, tumor necrosis factor-superfamily molecules, and transcription factor Runx2 could be used as markers of the form of arthritis, disease activity, and therapeutic responsiveness.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Peripheral blood expression pr ...... nd therapeutic responsiveness.
@en
Peripheral blood expression pr ...... nd therapeutic responsiveness.
@nl
type
label
Peripheral blood expression pr ...... nd therapeutic responsiveness.
@en
Peripheral blood expression pr ...... nd therapeutic responsiveness.
@nl
prefLabel
Peripheral blood expression pr ...... nd therapeutic responsiveness.
@en
Peripheral blood expression pr ...... nd therapeutic responsiveness.
@nl
P2093
P356
P1476
Peripheral blood expression pr ...... nd therapeutic responsiveness.
@en
P2093
Danka Grcevic
Frane Grubisic
Ivan Kresimir Lukic
Natasa Kovacic
Sanja Ivcevic
Vedran Velagic
Zrinka Jajic
P304
P356
10.3899/JRHEUM.090167
P407
P50
P577
2009-12-15T00:00:00Z